M. Grunewald

Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial.

P. Kienle, S. Post, F. Wenz, 2012, The Lancet. Oncology.

Capecitabine (Cape) versus 5-fluorouracil (5-FU)-based (neo)adjuvant chemoradiotherapy (CRT) for locally advanced rectal cancer (LARC): Long-term results of a randomized, phase III trial.

S. Post, F. Wenz, R. Hofheinz, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy of Prophylactic Low-Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial.

B. Dörken, M. Stauch, H. Oettle, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.